Gainers
-
Nabriva Therapeutics plc (NASDAQ: NBRV) rose 84.4
percent to $12.65 in pre-market trading after the company disclosed that its Phase 3 trial evaluating IV and oral lefamulin met
all primary FDA and EMA endpoints.
-
Silver Spring Networks Inc (NYSE: SSNI) rose 23.1
percent to $16.00 in pre-market trading. Itron, Inc. (NASDAQ: ITRI) announced plans to acquire Silver Spring Networks for $16.25 per share.
-
Orbital ATK Inc (NYSE: OA) rose 19.5 percent to
$131.50 in pre-market trading. Northrop Grumman Corporation (NYSE: NOC) announced plans to acquire Orbital ATK for $7.8 billion in cash.
-
Pluristem Therapeutics Inc. (NASDAQ: PSTI) rose
10.5 percent to $1.48 in pre-market trading after the company disclosed that it has been granted FDA Fast Track Designation for
PLX-PAD.
-
BioTime, Inc. (NYSE: BTX) rose 10.2 percent to $3.14
in pre-market trading after the company reported that it has been awarded a $1.56 million grant from the National Institutes of
Health.
-
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) rose
7.9 percent to $3.56 in pre-market trading after surging 18.28 percent on Friday. William Blair upgraded Arrowhead
Pharmaceuticals from Market Perform to Outperform.
-
Cogint, Inc. (NASDAQ: COGT) rose 6.3 percent to
$5.05 in pre-market trading after falling 4.04 percent on Friday.
-
BlackBerry Ltd (NASDAQ: BBRY) shares rose 6.2
percent to $9.84 in pre-market trading. BlackBerry is expected to release Q2 results on September 28, 2017.
-
BiondVax Pharmaceuticals Ltd (ADR) (NASDAQ: BVXV)
rose 5.6 percent to $7.50 in pre-market trading after gaining 1.07 percent on Friday.
-
Ballard Power Systems Inc. (USA) (NASDAQ: BLDP)
rose 5.2 percent to $4.66 in pre-market trading after the company reported that it has received a purchase order from Nisshinbo
for the development program to advance use of Non Precious Metal Catalyst fuel cells in material handling.
-
NewLink Genetics Corp (NASDAQ: NLNK) shares rose
5.2 percent to $13.33 in pre-market trading after falling 3.94 percent on Friday.
-
Rite Aid Corporation (NYSE: RAD) rose 5 percent to
$2.76 in pre-market trading after gaining 5.20 percent on Friday.
-
Pain Therapeutics, Inc. (NASDAQ: PTIE) shares
rose 2.9 percent to $4.00 in the pre-market trading session after the company announced that it has been awarded a $2.2 million
grant from the National Institute on Drug Abuse and $1.8 million grant from the National Institutes of Health.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
-
Helios and Matheson Analytics Inc (NASDAQ: HMNY)
shares fell 14.2 percent to $3.15 in pre-market trading after climbing 39.54 percent on Friday.
-
PDC Energy Inc (NASDAQ: PDCE) shares fell 5.6
percent to $41.35 in pre-market trading after rising 0.48 percent on Friday.
-
Neos Therapeutics Inc (NASDAQ: NEOS) fell 4.4
percent to $8.80 in pre-market trading. Neos Therapeutics disclosed that it has received the FDA approval for Adzenys ER.
-
22nd Century Group Inc (NYSE: XXII) fell 4.1
percent to $3.08 in pre-market trading after gaining 6.29 percent on Friday.
-
Royal Gold, Inc (USA) (NASDAQ: RGLD) shares fell
3.9 percent to $86.25 in pre-market trading after dropping 0.54 percent on Friday.
-
Harmony Gold Mining Co. (ADR). (NYSE: HMY) shares
fell 3.7 percent to $2.06 in pre-market trading after rising 2.88 percent on Friday.
-
Cedar Fair, L.P. (NYSE: FUN) fell 3.3 percent to
$62.52 in pre-market trading after dropping 0.52 percent on Frisday.
-
AngloGold Ashanti Limited (ADR) (NYSE: AU) fell 2.7
percent to $9.68 after rising 1.74 percent on Friday.
-
Chimera Investment Corporation (NYSE: CIM) fell 2.6
percent to $18.59 in pre-market trading after gaining 0.47 percent on Friday.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.